More than 40% of Dutch people experience mental health problems at least once in their lives. Mental illnesses affect both young and old and can have an enormous impact on sufferers and also on family members, friends and colleagues. Mental illnesses have a large societal impact.
ZonMw promotes, through several funding programmes, the early detection and identification of problems, their effective treatment, and the individualization of mental health care. We want to reduce the number of people with mental health problems, improve their quality of life and their treatment, prevent problem escalation, and avoid unnecessarily lengthy treatments.
ERANID, the European Research Area Network on Illicit Drugs, aims to improve cooperation in drug research in order to allow well-founded policy decisions, prevention and harm reduction interventions. ERANID is meant as a first step towards a longer term transnational cooperation in the field of drugs research.
Suicidal behaviour is argued to be the end result of the complex interaction between psychological, social and biological factors. Epidemiological studies resulted in a range of risk factors for suicidal behaviour, but we do not yet understand how their interaction increases the risk for suicidal behaviour. A new approach called network analysis can help us better understand this process as it allows us to visualize and quantify the complex association between many different symptoms or risk factors.
ZonMw organized a workshop on disturbed behavior during the International Conference on Integrated Care (ICIC) 2018. In our workshop we focussed on the concept of people with disturbed behavior and results form a qualitative and quantitative evaluation.
GloPID-R is pleased to welcome the Netherlands Organisation for Health Research and Development (ZonMw), represented by Suzanne Verver, into the network. GloPID-R is a unique international network of major research funding organizations. The network of 27 countries facilitates a rapid and effective research response to infectious disease outbreaks.
KNAW (Royal Netherlands Academy of Arts and Sciences), NWO (Netherlands Organisation for Scientific Research) and ZonMw (Netherlands Organisation for Health Research and Development) will sign the San Francisco Declaration on Research Assessment (DORA) on 18 April.
On April 1st 2019 the kick-off meeting of the European public-private partnership VALUE-Dx took place. This European-wide approach aims to generate evidence on the medical, economic, and public health value of diagnostics in tackling antimicrobial resistance (AMR). As a member of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), ZonMw participates in this consortium.
17 researchers who have recently received their PhDs can do their research at foreign research institutes thanks to a Rubicon grant from NWO. They will investigate, amongst other things, artificial intelligence for improved ultrasonography, Imaging muscle function in ALS patients, Printing living tissue through protective cell coating and new blood vessel formation.
While the pharmaceutical, medical technologies, chemical, cosmetics and food industries are increasingly seeking solutions to improve for example their prediction of clinical efficacy and/or risk and safety assessments without the use of animals, the solutions are still insufficient;
Societal demand for animal-free testing is increasing and there is a need for new innovations to improve human health, a stimulation of this research field is therefore needed;